Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography
- 31 May 1994
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 123 (1-2) , 44-51
- https://doi.org/10.1016/0022-510x(94)90202-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and positron emission tomographyBrain Research, 1994
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Regional cerebral glucose metabolism compared in rodents and humansBrain Research, 1991
- The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's DiseaseCerebral Cortex, 1991
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseAnnals of Neurology, 1985
- The Cholinergic Hypothesis: A Historical Overview, Current Perspective, and Future DirectionsAnnals of the New York Academy of Sciences, 1985
- ALZHEIMER'S DISEASE AND THE PARIETAL LOBEThe Lancet, 1983
- Physostigmine: Improvement of Long-Term Memory Processes in Normal HumansScience, 1978
- Physostigmine: Effects on cognition and affect in normal subjectsPsychopharmacology, 1976
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974